What Has Been the Progress and Growth of the Black Lung Disease Market in Recent Years?
The black lung disease market has seen considerable growth due to a variety of factors.
• Over the recent years, there's been a substantial escalation in the market size of black lung disease. The market is anticipated to expand from $9.66 billion in 2024 to $11.02 billion in 2025, marking an impressive compound annual growth rate (CAGR) of 14.1%.
This significant growth during the historic period is largely a result of the expansion of the coal mining industry, heightened awareness and education, increased compensation and benefits, and advancements in legislative and legal platforms.
What Can Be Expected from the Black Lung Disease Market Size?
The black lung disease market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for black lung disease is projected to witness accelerated expansion in the coming years, reaching $19.42 billion by 2029 with a compound annual growth rate (CAGR) of 15.2%.
The predicted surge during the forecast period is largely due to factors like initiatives in public health, advancements in medicinal sciences, proliferation of treatment choices, and the influence of advocacy and sustenance groups. The forecast period will also probably see significant trends such as the application of advanced diagnostic methods, increased investment in research and prevention, improved healthcare accessibility, and progress in technology.
What Are the Critical Driver Fuelling The Black Lung Disease Market's Growth?
Higher mining activities are anticipated to fuel the black lung disease market's growth. These activities entail extracting valuable minerals, ores, and other geological materials from the earth. Black lung disease stems from mining undertakings and inhaling coal mine dust, which is laden with harmful carbon particles, severely impacting coal miners. For example, the International Energy Agency (IEA), a France-based intergovernmental organization, reported in July 2023, that the production of critical minerals witnessed a sizeable boost, growing by 30% to reach $41 billion in 2022, a rise from a 20% growth in 2021. The past five years have seen the demand for critical minerals increase considerably, with lithium consumption tripling and cobalt demand going up by 70%. Thus, higher mining activities are leading to the growth of the black lung disease market. The rise in tuberculosis prevalence is anticipated to fuel the growth of the black lung disease market. Tuberculosis is a bacterial infection mainly caused by Mycobacterium tuberculosis that spreads when an infected person coughs or sneezes, leading to symptoms such as coughing, fever, weight loss, and fatigue. The rise in tuberculosis prevalence plays a role in black lung disease as individuals with tuberculosis carry a higher risk of developing black lung disease and are more likely exposed to coal dust. In March 2023, the Centers for Disease Control and Prevention, a US-based public health agency, reported 8,300 cases of tuberculosis in 2022 in the US, an increase from 7,874 cases in 2021. Hence, the rise in tuberculosis prevalence is fuelling the black lung disease market growth.
How Is The Black Lung Disease Market segmented?
The black lung disease market covered in this report is segmented –
1) By Type: Simple Coal Worker’s Pneumoconiosis, Complicated Coal Worker’s Pneumoconiosis, Other Types
2) By Treatment: Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell Therapy, Other Treatment
3) By Diagnosis: Biopsy, Imaging, Full Blood Count, Pulmonary Or Lung Function Tests, Physical Examination, Other Diagnosis
4) By End Users: Hospitals And Clinics, Research Organizations And Academic Institutes, Diagnostic Centers And Labs, Other End Users
Subsegments:
1) By Simple Coal Worker’s Pneumoconiosis: Asymptomatic Simple Pneumoconiosis, Symptomatic Simple Pneumoconiosis
2) By Complicated Coal Worker’s Pneumoconiosis: Progressive Massive Fibrosis (PMF), Complicated Pneumoconiosis With Respiratory Symptoms
3) By Other Type: Mixed Dust Pneumoconiosis, Other Related Respiratory Diseases
Pre-Book The Black Lung Disease Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Who Are the Key Players In The Black Lung Disease Market?
Major companies operating in the black lung disease market are:
• Pfizer Inc.
• Johnson and Johnson
• Siemens AG
• General Electric
• F. Hoffmann-La Roche AG
• Merck and Co. Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• AstraZeneca PLC
• Melinta Therapeutics LLC
• GlaxoSmithKline PLC
• Medtronic PLC
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Toshiba Corporation
• Koninklijke Philps N.V.
• Mayo Clinic
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Sun Pharmaceutical Industries Ltd.
• Perrigo Lab India Pvt. Ltd.
• Aurobindo Pharma Limited
• Hikma Pharmaceuticals PLC
• Lupin Limited.
What Is The Most Dominant Region In The Black Lung Disease Market?
North America was the largest region in the black lung disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in black lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
